Zobrazeno 1 - 10
of 265
pro vyhledávání: '"Eliezer A. Rachmilewitz"'
Autor:
Eitan Fibach, Eliezer A. Rachmilewitz
Publikováno v:
F1000Research, Vol 6 (2017)
Thalassemia (thal) is an autosomal recessive, hereditary, chronic hemolytic anemia due to a partial or complete deficiency in the synthesis of α-globin chains (α-thal) or β-globin chains (β-thal) that compose the major adult hemoglobin (α2β2).
Externí odkaz:
https://doaj.org/article/407a6df142194197badc52ef559b55f0
Publikováno v:
Haematologica, Vol 98, Iss 6 (2013)
Non-transfusion-dependent thalassemias include a variety of phenotypes that, unlike patients with beta (β)-thalassemia major, do not require regular transfusion therapy for survival. The most commonly investigated forms are β-thalassemia intermedia
Externí odkaz:
https://doaj.org/article/4b7a2d3009514cc598e1aa7828f5b3e6
Autor:
Eitan Fibach, Eliezer A. Rachmilewitz
Publikováno v:
La Presse Médicale. 46:e296-e305
While most common symptom of impairment of iron homeostasis is iron deficiency anemia, some hematological disorders are associated with iron overload (IO). These disorders are related mainly to chronic severe hemolytic anemia, where red blood cells (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8450e86bd4a4e2aa4d9cca283e1034c1
https://doi.org/10.1016/j.lpm.2017.10.007
https://doi.org/10.1016/j.lpm.2017.10.007
Publikováno v:
Critical Reviews in Oncology/Hematology. 113:156-170
Iron is an essential element for key cellular metabolic processes. However, transfusional iron overload (IOL) may result in significant cellular toxicity. IOL occurs in transfusion dependent hematologic malignancies (HM), may lead to pathological cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a30fd2c3f51bd6529f33ef012e885992
https://doi.org/10.1016/j.critrevonc.2017.03.002
https://doi.org/10.1016/j.critrevonc.2017.03.002
Publikováno v:
Genetically Abnormal Red Cells ISBN: 9780429263989
Genetically Abnormal Red Cells
Genetically Abnormal Red Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c251bf4dea7a28cd582f749d1df988aa
https://doi.org/10.1201/9780429263989-5
https://doi.org/10.1201/9780429263989-5
Publikováno v:
Hemoglobin. 41(2)
β-Thalassemia (β-thal) is a very common disease in the Palestinian population of the Gaza Strip. We studied their mutation frequency and clinical features. Thirteen different mutations were identified. The most common mutation was IVS-I-1 (G>A) (HB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bce9431b6ebc0fda45c8da69bd5bd0fe
https://pubmed.ncbi.nlm.nih.gov/28670942
https://pubmed.ncbi.nlm.nih.gov/28670942
Publikováno v:
Blood. 124:873-881
Myelodysplastic syndromes (MDSs) are a group of heterogeneous clonal bone marrow disorders characterized by ineffective hematopoiesis, peripheral blood cytopenias, and potential for malignant transformation. Lower/intermediate-risk MDSs are associate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97ac9098defcbf4f81257c94703b5e52
https://doi.org/10.1182/blood-2014-03-563221
https://doi.org/10.1182/blood-2014-03-563221
Publikováno v:
Thrombosis Research. 130:695-702
Despite remarkable advances in understanding cerebrovascular disease attributed to sickle cell anemia, data from other hemoglobinopathies have only recently started to emerge. Several brain magnetic resonance imaging studies confirm a high prevalence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a96cc6a0e17574808a1838f89de5bb0c
https://doi.org/10.1016/j.thromres.2012.07.013
https://doi.org/10.1016/j.thromres.2012.07.013
Autor:
Hussam Ghoti, Eliezer A. Rachmilewitz, Orly Goitein, Eli Konen, Eitan Fibach, Ramon Simon-Lopez, Natascia Campostrini, Ze'ev Katzir, Tamar Kushnir, Raed Gaber, Domenico Girelli
Publikováno v:
European Journal of Haematology. 89:87-93
Erythropoiesis in long-term hemodialyzed (LTH) patients is supported by erythropoietin (rHuEpo) and intravenous (IV) iron. This treatment may end up in iron overload (IO) in major organs. We studied such patients for the parameters of IO in the serum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b00ebd38367cd2ab684a40822e13d76
https://doi.org/10.1111/j.1600-0609.2012.01783.x
https://doi.org/10.1111/j.1600-0609.2012.01783.x
Autor:
Francesca Vinchi, Richard Sparla, Eliezer A. Rachmilewitz, Hala Zreid, Rushdy Rasras, Martina U. Muckenthaler, Gregory M. Vercellotti, John D. Belcher, Eitan Fibach, Hussam Ghoti
Publikováno v:
Atherosclerosis. 263:e107-e108
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::851733bfc5d36a00bfa80a596bec96b7
https://doi.org/10.1016/j.atherosclerosis.2017.06.344
https://doi.org/10.1016/j.atherosclerosis.2017.06.344